blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1913016

EP1913016 - MACROCYCLIC PEPTIDES AS HCV NS3 PROTEASE INHIBITORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  22.11.2013
Database last updated on 18.11.2024
Most recent event   Tooltip17.07.2015Lapse of the patent in a contracting state
New state(s): HU, LU		published on 19.08.2015  [2015/34]
Applicant(s)For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
[2013/03]
Former [2012/33]For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway NJ 07065-0907 / US
Former [2012/32]For all designated states
Schering Corporation
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
Former [2010/10]For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway, NJ 07065 / US
Former [2008/17]For all designated states
Merck & Co., Inc.
126 East Lincoln Avenue
Rahway, New Jersey 07065-0907 / US
Inventor(s)01 / HOLLOWAY, M., Katharine
126 East Lincoln Avenue
Rahway, New Jersey 07065-0907 / US
02 / LIVERTON, Nigel, J.
126 East Lincoln Avenue
Rahway, New Jersey 07065-0907 / US
03 / MCCAULEY, John, A.
126 East Lincoln Avenue
Rahway, New Jersey 07065-0907 / US
04 / RUDD, Michael, T.
126 East Lincoln Avenue
Rahway, New Jersey 07065-0907 / US
05 / VACCA, Joseph, P.
126 East Lincoln Avenue
Rahway, New Jersey 07065-0907 / US
06 / LUDMERER, Steven, W.
126 East Lincoln Avenue
Rahway, New Jersey 07065-0907 / US
07 / OLSEN, David, B.
126 East Lincoln Avenue
Rahway, New Jersey 07065-0907 / US
 [2008/17]
Representative(s)Horgan, James Michael Frederic
Merck Sharp & Dohme Corp.
120 Moorgate
London, EC2M 6UR / GB
[N/P]
Former [2013/03]Horgan, James Michael Frederic
Merck & Co., Inc. European Patent Department Hertford Road Hoddesdon
EN11 9BU / GB
Former [2008/17]Horgan, James Michael Frederic
Merck & Co., Inc. European Patent Department Hertford Road Hoddesdon
Hertfordshire EN11 9BU / GB
Application number, filing date06800513.128.07.2006
[2008/17]
WO2006US29635
Priority number, dateUS20050704256P01.08.2005         Original published format: US 704256 P
US20050724509P07.10.2005         Original published format: US 724509 P
[2008/17]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2007016441
Date:08.02.2007
Language:EN
[2007/06]
Type: A1 Application with search report 
No.:EP1913016
Date:23.04.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 08.02.2007 takes the place of the publication of the European patent application.
[2008/17]
Type: B1 Patent specification 
No.:EP1913016
Date:16.01.2013
Language:EN
[2013/03]
Search report(s)International search report - published on:EP08.02.2007
ClassificationIPC:C07K5/08, C07K5/10, C07K7/06, A61K38/06, A61K38/07, A61K38/08, A61P31/14
[2008/17]
CPC:
C07K5/0812 (EP,US); C07K5/12 (KR); A61K38/06 (KR);
A61P31/12 (EP); A61P31/14 (EP); A61P43/00 (EP);
C07K5/0827 (EP,US); C07K5/10 (KR); C07K7/06 (KR);
A61K38/00 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/17]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
RSNot yet paid
TitleGerman:MAKROCYCLISCHE PEPTIDE ALS HCV-NS3 -PROTEASEHEMMER[2008/17]
English:MACROCYCLIC PEPTIDES AS HCV NS3 PROTEASE INHIBITORS[2008/17]
French:PEPTIDES MACROCYCLIQUES EN TANT QU INHIBITEURS DE LA PROTÉASE NS3 DU VHC[2008/17]
Entry into regional phase03.03.2008National basic fee paid 
03.03.2008Designation fee(s) paid 
03.03.2008Examination fee paid 
Examination procedure03.03.2008Examination requested  [2008/17]
18.08.2010Despatch of a communication from the examining division (Time limit: M04)
23.12.2010Reply to a communication from the examining division
30.07.2012Communication of intention to grant the patent
04.12.2012Fee for grant paid
04.12.2012Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  18.08.2010
Opposition(s)17.10.2013No opposition filed within time limit [2013/52]
Fees paidRenewal fee
27.03.2008Renewal fee patent year 03
08.07.2009Renewal fee patent year 04
08.07.2010Renewal fee patent year 05
16.07.2011Renewal fee patent year 06
06.07.2012Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU28.07.2006
AT16.01.2013
BE16.01.2013
CY16.01.2013
CZ16.01.2013
DK16.01.2013
EE16.01.2013
FI16.01.2013
IT16.01.2013
LT16.01.2013
LV16.01.2013
MC16.01.2013
PL16.01.2013
RO16.01.2013
SE16.01.2013
SI16.01.2013
SK16.01.2013
TR16.01.2013
BG16.04.2013
GR17.04.2013
ES27.04.2013
IS16.05.2013
PT16.05.2013
IE28.07.2013
LU28.07.2013
[2015/34]
Former [2015/32]AT16.01.2013
BE16.01.2013
CY16.01.2013
CZ16.01.2013
DK16.01.2013
EE16.01.2013
FI16.01.2013
IT16.01.2013
LT16.01.2013
LV16.01.2013
MC16.01.2013
PL16.01.2013
RO16.01.2013
SE16.01.2013
SI16.01.2013
SK16.01.2013
TR16.01.2013
BG16.04.2013
GR17.04.2013
ES27.04.2013
IS16.05.2013
PT16.05.2013
IE28.07.2013
Former [2014/33]AT16.01.2013
BE16.01.2013
CY16.01.2013
CZ16.01.2013
DK16.01.2013
EE16.01.2013
FI16.01.2013
IT16.01.2013
LT16.01.2013
LV16.01.2013
MC16.01.2013
PL16.01.2013
RO16.01.2013
SE16.01.2013
SI16.01.2013
SK16.01.2013
BG16.04.2013
GR17.04.2013
ES27.04.2013
IS16.05.2013
PT16.05.2013
IE28.07.2013
Former [2014/14]AT16.01.2013
BE16.01.2013
CY16.01.2013
CZ16.01.2013
DK16.01.2013
EE16.01.2013
FI16.01.2013
IT16.01.2013
LT16.01.2013
LV16.01.2013
MC16.01.2013
PL16.01.2013
RO16.01.2013
SE16.01.2013
SI16.01.2013
SK16.01.2013
BG16.04.2013
GR17.04.2013
ES27.04.2013
IS16.05.2013
PT16.05.2013
Former [2014/03]AT16.01.2013
BE16.01.2013
CY16.01.2013
CZ16.01.2013
DK16.01.2013
EE16.01.2013
FI16.01.2013
IT16.01.2013
LT16.01.2013
LV16.01.2013
PL16.01.2013
RO16.01.2013
SE16.01.2013
SI16.01.2013
SK16.01.2013
BG16.04.2013
GR17.04.2013
ES27.04.2013
IS16.05.2013
PT16.05.2013
Former [2013/52]AT16.01.2013
BE16.01.2013
CY16.01.2013
CZ16.01.2013
DK16.01.2013
EE16.01.2013
FI16.01.2013
LT16.01.2013
LV16.01.2013
PL16.01.2013
RO16.01.2013
SE16.01.2013
SI16.01.2013
SK16.01.2013
BG16.04.2013
GR17.04.2013
ES27.04.2013
IS16.05.2013
PT16.05.2013
Former [2013/49]AT16.01.2013
BE16.01.2013
CZ16.01.2013
DK16.01.2013
EE16.01.2013
FI16.01.2013
LT16.01.2013
LV16.01.2013
PL16.01.2013
RO16.01.2013
SE16.01.2013
SI16.01.2013
SK16.01.2013
BG16.04.2013
GR17.04.2013
ES27.04.2013
IS16.05.2013
PT16.05.2013
Former [2013/48]AT16.01.2013
BE16.01.2013
DK16.01.2013
EE16.01.2013
FI16.01.2013
LT16.01.2013
LV16.01.2013
PL16.01.2013
SE16.01.2013
SI16.01.2013
BG16.04.2013
GR17.04.2013
ES27.04.2013
IS16.05.2013
PT16.05.2013
Former [2013/40]AT16.01.2013
BE16.01.2013
FI16.01.2013
LT16.01.2013
LV16.01.2013
PL16.01.2013
SE16.01.2013
SI16.01.2013
BG16.04.2013
GR17.04.2013
ES27.04.2013
IS16.05.2013
PT16.05.2013
Former [2013/38]AT16.01.2013
BE16.01.2013
FI16.01.2013
LT16.01.2013
LV16.01.2013
PL16.01.2013
SE16.01.2013
SI16.01.2013
BG16.04.2013
GR17.04.2013
ES27.04.2013
IS16.05.2013
Former [2013/37]AT16.01.2013
BE16.01.2013
FI16.01.2013
LT16.01.2013
PL16.01.2013
SE16.01.2013
SI16.01.2013
BG16.04.2013
GR17.04.2013
ES27.04.2013
IS16.05.2013
Former [2013/36]AT16.01.2013
BE16.01.2013
LT16.01.2013
PL16.01.2013
SE16.01.2013
BG16.04.2013
ES27.04.2013
IS16.05.2013
Former [2013/35]BE16.01.2013
LT16.01.2013
SE16.01.2013
BG16.04.2013
IS16.05.2013
Former [2013/34]LT16.01.2013
SE16.01.2013
BG16.04.2013
IS16.05.2013
Former [2013/33]LT16.01.2013
Cited inInternational search[Y]WO0009543  (BOEHRINGER INGELHEIM CA LTD [CA], et al) [Y] 1-31 * abstract * * example - * * claim - *;
 [Y]WO03064455  (BOEHRINGER INGELHEIM CA LTD [CA], et al) [Y] 1-31 * abstract * * example - * * claim - *;
 [A]  - POUPART ET AL, J.ORG.CHEM., (2001), vol. 66, no. 14, pages 4743 - 4751, XP002408789 [A] 1-31 * abstract * * page 4744; examples 4-6,8 * * page 4745; table 1 *

DOI:   http://dx.doi.org/10.1021/jo010164d
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.